Conditions: Gastroesophageal Reflux Disease GERD Heartburn
Keywords: gastroesophageal reflux disease GERD heartburn
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 138
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the efficacy, acceptability, and safety of Axid Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in infants age 30 days up to 1 year.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: nizatidine (axid) intervention 2: nizatidine (axid) intervention 3: placebo
Intervention descriptions: intervention 1: nizatidine (axid) intervention 2: nizatidine (axid) intervention 3: placebo

Protocol document: